Factor | No. of patients | Progression rate,% | p value |
---|---|---|---|
Gender | |||
Male | 7/13 | 53.8% | 0.475 |
Female | 1/8 | 12.5% | |
Age | |||
≤ 50 | 4/11 | 36.3% | 0.835 |
> 50 | 4/10 | 40.0% | |
Tumor size(cm) | |||
≤ 4 | 3/12 | 25.0% | 0.020* |
> 4 | 5/9 | 55.6% | |
Tumor number | |||
SP | 5/18 | 27.8% | 0.114 |
MSP | 3/3 | 100% | |
SUVmax | |||
≤ 5.5 | 2/9 | 22.2% | 0.627 |
> 5.5 | 6/11 | 54.5% | |
Response to therapy | |||
CR | 3/13 | 23.1% | 0.040* |
PR | 5/8 | 62.5% |